PL346549A1 - Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants - Google Patents

Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants

Info

Publication number
PL346549A1
PL346549A1 PL99346549A PL34654999A PL346549A1 PL 346549 A1 PL346549 A1 PL 346549A1 PL 99346549 A PL99346549 A PL 99346549A PL 34654999 A PL34654999 A PL 34654999A PL 346549 A1 PL346549 A1 PL 346549A1
Authority
PL
Poland
Prior art keywords
enterotoxin
peptide fragments
cholera toxin
vaccine adjuvants
vaccine
Prior art date
Application number
PL99346549A
Other languages
English (en)
Inventor
Neil Andrew Williams
Timothy Raymond Hirst
Original Assignee
Univ Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol filed Critical Univ Bristol
Publication of PL346549A1 publication Critical patent/PL346549A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL99346549A 1998-09-07 1999-09-07 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants PL346549A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9819484.8A GB9819484D0 (en) 1998-09-07 1998-09-07 Therapeutic agents
PCT/GB1999/002970 WO2000014114A1 (en) 1998-09-07 1999-09-07 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants

Publications (1)

Publication Number Publication Date
PL346549A1 true PL346549A1 (en) 2002-02-11

Family

ID=10838466

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99346549A PL346549A1 (en) 1998-09-07 1999-09-07 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants

Country Status (19)

Country Link
EP (1) EP1109828A1 (is)
JP (1) JP2002524469A (is)
KR (1) KR20010044842A (is)
CN (1) CN1317013A (is)
AU (1) AU772015B2 (is)
BR (1) BR9913501A (is)
CA (1) CA2338384A1 (is)
CZ (1) CZ2001839A3 (is)
EA (1) EA200100314A1 (is)
GB (2) GB9819484D0 (is)
HU (1) HUP0104090A2 (is)
IL (1) IL141695A0 (is)
IS (1) IS5829A (is)
MX (1) MXPA01002387A (is)
NO (1) NO20011075L (is)
NZ (1) NZ509631A (is)
PL (1) PL346549A1 (is)
WO (1) WO2000014114A1 (is)
ZA (1) ZA200100758B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010036917A1 (en) 1995-07-05 2001-11-01 Williams Neil Andrew Therapeutic agents
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
GB0115382D0 (en) 2001-06-22 2001-08-15 Univ Bristol Mutant
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
CN104402974B (zh) * 2014-12-10 2017-11-14 重庆医科大学 一种具有粘膜免疫佐剂活性的多肽及其在制备粘膜免疫佐剂中的用途
WO2024121125A1 (en) * 2022-12-06 2024-06-13 Bactolife A/S Single-domain antibodies to reduce the risk of cholera infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527445A1 (fr) * 1982-05-26 1983-12-02 Centre Nat Rech Scient Medicaments contenant au moins une sequence de la sous-unite b1 de la toxine cholerique
IL69558A (en) * 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
ZA839512B (en) * 1983-12-12 1984-08-29 Scripps Clinic Res Synthetic heat-stable enterotoxin polypeptide of escherichia coli and multimers thereof
FR2636842B1 (fr) * 1988-09-27 1994-06-10 Liege Universite Etat Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion
CA2180726A1 (en) * 1994-01-27 1995-08-03 Evgeni Veniaminovic Sokurenko Receptor specific bacterial adhesins and their use
IL109519A (en) * 1994-05-03 1999-03-12 Yeda Res & Dev Vaccines for oral immunization against infecting agents
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant

Also Published As

Publication number Publication date
AU772015B2 (en) 2004-04-08
BR9913501A (pt) 2001-06-05
GB0107375D0 (en) 2001-05-16
JP2002524469A (ja) 2002-08-06
WO2000014114A1 (en) 2000-03-16
HUP0104090A2 (hu) 2002-01-28
EP1109828A1 (en) 2001-06-27
AU5751699A (en) 2000-03-27
NZ509631A (en) 2003-11-28
GB2357507A (en) 2001-06-27
CN1317013A (zh) 2001-10-10
CA2338384A1 (en) 2000-03-16
ZA200100758B (en) 2001-07-16
EA200100314A1 (ru) 2001-10-22
IL141695A0 (en) 2002-03-10
MXPA01002387A (es) 2002-05-08
IS5829A (is) 2001-03-07
GB9819484D0 (en) 1998-10-28
NO20011075D0 (no) 2001-03-02
KR20010044842A (ko) 2001-06-05
NO20011075L (no) 2001-05-07
CZ2001839A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
AU1914595A (en) Isolated antigenic oncogene peptide fragments and uses
IL151355A0 (en) Vaccine for the treatment of artherosclerosis
ZA978868B (en) Vaccine composition
AU2001277961A1 (en) Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
AU1508699A (en) Live attenuated influenza vaccine
PL331424A1 (en) Antipaludian vaccine composition
ZA979984B (en) Vaccine composition
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
FI20070041L (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
IL141695A0 (en) Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
AUPQ712000A0 (en) Antigenic peptide fragments of VapA protein, and uses thereof
ZA9711565B (en) Vaccine
AU4450696A (en) Enhanced immunogenic vaccine
GB9611673D0 (en) Meningococcal vaccine
GB2331521B (en) Vaccine preparations
AU3755999A (en) Proteins that direct the secretion of virulence proteins and vaccines comprisingthem
HK1036807A (en) Peptide fragments os cholera toxin b or enterotoxin b as vaccine adjuvants
AU2548597A (en) Antibodies against avirulence/pathogenicity proteins of plant pathogens
AU2002221760A1 (en) Vaccine for treating allergy
AU2001267613A1 (en) Adjuvant composition comprising FHA protein or fragment of FHA protein in free form
HU9502051D0 (en) Babesia vaccine
AU2144499A (en) Live attenuated salmonella vaccine
GB9614618D0 (en) Vaccine compositions
GB9625968D0 (en) Vaccine

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)